SBIR/STTR Research Award

AN ULTRASOUND SYSTEM FOR THE TREATMENT OF WARTS

Award identifier af057c13a188a5b7dafe593474fbb2cc8063b89145d0ec014543d47231536ed2Awarding agency Department of Health and Human Services

Award amount

$50,000

Program and phase

SBIR · Phase I

Award year

1988

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Not reported
Recipient company
Ultrathermics Inc
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

VIRAL WARTS ARE AN AFFLICTION FOR WHICH NEW MODALITIES OF TREATMENT ARE NEEDED, ESPECIALLY FOR LARGE, FLAT, RESISTANT AND/OR CLUSTERED LESIONS. PATIENTS AND PHYSICIANS ALIKE AREFRUSTRATED BECAUSE NONE OF THE EXISTING THERAPIES IS COMPLETELY SATISFACTORY. PRELIMINARY CLINICAL STUDIES INDICATE THAT WARTS, LIKE CANCER TUMORS, MAY BE CLEARED AS ARESULT OF BEING HEATED TO TEMPERATURES IN THE HYPERTHERMIC RANGE (42-47 DEGREES (C)). PROPOSED IS THE DEVELOPMENT OF ARELATIVELY SIMPLE AND INEXPENSIVE HYPERTHERMIA SYSTEM CAPABLE OF TREATING WARTS AND OTHER HEAT-SENSITIVE SKIN DISEASES. THE DEVICE, A PORTABLE, SELF-CONTAINED, MICROPROCESSOR-CONTROLLED SYSTEM WELL SUITED FOR USE IN AN OFFICE PRACTICE, WILL BE CAPABLE OF PRODUCING TAILORED THERMAL DISTRIBUTIONS IN SKIN TISSUES BY DYNAMICALLY CONTROLLING THE ACOUSTIC FREQUENCY AND POWER OUTPUT OF AN ULTRASOUND TRANSDUCER, AND THE TEMPERATURE OF THE WATER BOLUS THAT COUPLES THE ENERGY TO THE BODY. PHASE I OF THIS PROJECT SEEKS TO DEMONSTRATE THE FEASIBILITYOF THIS CONCEPT BY FABRICATING SEVERAL CLINICALLY USEFUL APPLICATORS AND TESTING THEIR PERFORMANCE BOTH IN THE LABORATORY AND CLINIC. KEY TO THE SUCCESS OF THIS PHASE IS THE DEVELOPMENT OF A TRANSDUCER CAPABLE OF EFFICIENTLY AND UNIFORMLY RADIATING ULTRASOUND OVER THE FREQUENCY RANGE FROM5 TO 10 MHZ, AND THE SUCCESSFUL COMPLETION OF PILOT CLINICAL STUDIES DEMONSTRATING SAFETY AND EFFICACY FOR CLEARING HUMAN WARTS. BASED ON PHASE I RESULTS, PHASE II WILL REQUEST FUNDING TO DEVELOP THE DEDICATED ELECTRONICS PACKAGE AND FLUID CONDITIONING HARDWARE NECESSARY TO PRODUCE A PROTOTYPE DEVICE AND TO CONDUCT FULL SCALE CLINICAL TRIALS. FROM THESE INVESTIGATIONS, IT IS ANTICIPATED THAT OPTIMIZED TREATMENT PROTOCOLS WILL EMERGE THAT CONFIRM THE POTENCY OF THIS NEW THERAPY, AND THEREBY CREATE DEMAND FOR COMMERCIAL SYSTEMS.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.